Potassium channel blockers as immunosuppressants

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.15, Iss.9, 2005-09, pp. : 1209-1220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Interactions Between hERG Potassium Channel and Blockers

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 4, 2009-03 ,pp. : 330-338

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Potassium Channel Blockers on the Action Potentials and Contractility of the Rat Right Ventricle

By Doggrell S.A. Bishop B.E.

General Pharmacology, Vol. 27, Iss. 2, 1996-03 ,pp. : 379-385

Elsevier

Access to resources Recommend Favorite

Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840

By Wulff Heike

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1759-1765

Informa Healthcare

Access to resources Recommend Favorite

A QSAR Study on Some Series of Sodium and Potassium Channel Blockers

Medicinal Chemistry, Vol. 5, Iss. 6, 2009-11 ,pp. : 570-576

Bentham Science Publishers

Access to resources Recommend Favorite

A Quantitative Structure-Activity Relationship Study on Some Series of Potassium Channel Blockers

Medicinal Chemistry, Vol. 5, Iss. 1, 2009-01 ,pp. : 87-92

Bentham Science Publishers

Access to resources Recommend Favorite